HHealthcare Read More Life Biosciences lands $80m to push cell reset therapyApril 9, 2026 Fresh funding backs the first human trial of a therapy designed to make older, damaged cells act younger…
NNutrition Read More SuppCo launches certification to verify actives in dietary supplementsMarch 3, 2026 The new program complements SuppCo’s TrustScore supplement quality rating system and builds on earlier testing initiatives, which revealed…
NNutrition Read More Why clinical trials on nutritional supplements are hard to designFebruary 27, 2026 Walk into any drugstore, natural market, or Costco and you’ll find a dazzling array of supplements promising everything…
HHealthcare Read More Klothea initiates longevity-focused human trial of klotho therapyFebruary 25, 2026 Recruitment for Phase 1 trial of mRNA therapy begins in ‘special economic zone’ on the Caribbean island of…
MMedication Read More Novartis remibrutinib first therapy to achieve Phase III primary endpoint in chronic inducible urticaria (CIndU)February 21, 2026 Statistically significant and clinically meaningful results seen in RemIND trial with complete responses achieved in 3 CIndU types1Remibrutinib,…
MMedication Read More Fact Check Team: GLP-1 users getting rare pirate diseaseFebruary 21, 2026 WASHINGTON (TNND) — Popular GLP-1 weight-loss medications have helped millions of people shed pounds, but new research from…
MMental health Read More Compass Pathways soars as psilocybin depression treatment hits second Phase 3 trial goals – Endpoints NewsFebruary 17, 2026 Compass Pathways soars as psilocybin depression treatment hits second Phase 3 trial goals Endpoints NewsBREAKING: Second Positive Phase 3…
MMedication Read More Disc Medicine Receives Complete Response Letter from FDA for Bitopertin for the Treatment of EPPFebruary 14, 2026 Disc Medicine Inc FDA acknowledged that AURORA and BEACON provided sufficient evidence that bitopertin significantly lowers PPIX and…
MMedication Read More FDA approves new menopause drug without hormones. Here’s what to know.October 28, 2025 The U.S. Food and Drug Administration has approved Lynkuet, a new daily pill from Bayer that provides a…
GGenetics Read More New Guides: Understanding Dementia Risk, Genetics, Diagnosis in Communities of ColorOctober 14, 2025 Is an Alzheimer’s clinical trial right for you? What does it mean to enroll in an Alzheimer’s clinical…
MMedication Read More Can Patients Skip Fasting With Higher Levothyroxine Dose?September 21, 2025 SCOTTSDALE, AZ — Among patients with hypothyroidism, administering a higher dose of levothyroxine with breakfast preserved thyroid-stimulating hormone…
MMedication Read More Rivaroxaban or Combo Therapy: A Winner for All Ages? – MedscapeAugust 21, 2025 Rivaroxaban or Combo Therapy: A Winner for All Ages? MedscapeRivaroxaban Monotherapy Benefits Those with Atrial Fibrillation, Stable Coronary Artery…